Sample multiplexing for Xenium – Bioptimus x Explicyte Case Study

Sample multiplexing Xenium Bioptimus

Table of Contents

This study in partnership with AI company Bioptimus addresses cost and throughput.

We doubled the number of FFPE samples per Xenium slide and ran a rigorous head-to-head against the “standard” format. Across QC metrics, cell-type proportions, and gene expression profiles, the data held up — with sample-to-sample correlations between formats reaching near-perfect agreement.

This sample multiplexing strategy is paving the way for faster & more cost-effective Xenium studies in large cohorts.

Download the case study: “Sample multiplexing for Xenium - Bioptimus x Explicyte Case Study”

Could your program use this approach?
Talk to us
Explicyte Oncology CRO logo

Capabilities

Modalities